Devin Duffy

Devin Duffy is an Advocacy and Policy Associate for the Roosevelt Institute who contributes to the advocacy, programs, and development efforts of the organization. Previously, he interned in the U.S. Senate and with the public interest group Americans for Financial Reform. He is a 2015 graduate of the University of Notre Dame.

In “The Cost of Capture: How the Pharmaceutical Industry Has Corrupted Policymakers and Harmed Patients,” Roosevelt Fellow Julie Margetta Morgan and Advocacy Associate Devin Duffy explore how drug companies influence policymakers and what this means for patients, the American health care system, and our economy. One of a series on Big Pharma, this issue brief

The pharmaceutical industry isn’t working for most people in the US. Over 80 percent of Americans across the political spectrum believe that lowering drug costs should be a “top priority” for lawmakers and believe that prescription drug costs are “unreasonable.” This growing scrutiny presents an opportunity to question the ways that drug corporations run business, as

Below please find the full video of the Roosevelt Institute and GWIPP’s Market Power Rising: Do we Have a Monopoly Moment? Event Info: Are we in a monopoly moment? From Amazon’s purchase of Whole Foods, to multi-billion dollar fines for Google in the EU, to the future of Net Neutrality, the intersection of competition policy

Tagged under: ,
TOP